James Ward-Lilley, the chief executive officer of innovative pharmaceutical firm Vectura, is to step down at the end of this month just over three years after turning it into a £1bn business. James, pictured, joined the Chippenham-based firm, which pioneering new ways of treating asthma and lung diseases, in June 2015 from pharma giant...